IMPORTANCE Previous studies investigating the association of single-nucleotide polymorphisms (SNPs) that confer increased risk of age-related macular degeneration (AMD) with pseudodrusen have yielded conflicting results and have not evaluated other AMD SNPs or pseudodrusen subtypes.
D rusen, or focal deposits of extracellular material external to the retinal pigment epithelium, are the hallmark of age-related macular degeneration (AMD). Pseudodrusen are subretinal deposits but are located internal to the retinal pigment epithelium. They are a distinct feature of AMD. Although pseudodrusen are a risk factor for advanced AMD, the pathophysiologic mechanism is unclear. 1, 2 Studies of the influence of genes on pseudodrusen have conflicting results. [3] [4] [5] [6] [7] [8] [9] [10] [11] The Comparison of AMD Treatments Trials (CATT) 12 compared the efficacy of treatment with ranibizumab or bevacizumab for neovascular AMD. In CATT, fellow eyes with baseline pseudodrusen had a 2-fold increased risk of developing neovascular AMD or geographic atrophy within 2 years after accounting for large drusen, pigmentary changes, and other risk factors. 2 Also, dot pseudodrusen were associated only with neovascular AMD, whereas confluent pseudodrusen were associated only with geographic atrophy. 2 A subgroup of CATT participants provided blood samples for genetic testing, allowing evaluation of the association between AMDassociated SNPs and pseudodrusen. 13 
Methods
This is a post hoc analysis of CATT data. Details of the CATT methodology and CATT genetics study have been published previously. 2, 12, 13 Written informed consent was obtained from all study participants. Institutional review board approval was obtained by all participating centers.
Genotype Determination
DNA was extracted and purified from leukocytes, as previously described. 13 The following 8 AMD-associated SNPs were evaluated using 
Pseudodrusen Evaluation
Pseudodrusen in each eye at baseline were graded using color fundus photography, red-free images, and fluorescein angiography. 2 Digital color fundus photographs were reviewed with the green channel only and the blue channel only in Adobe Photoshop because pseudodrusen are usually more visible under these conditions. Fluorescein angiography images were used to distinguish pseudodrusen from other drusen. Dot pseudodrusen were identified as discrete, round to oval dots, with areas between dot pseudodrusen exhibiting no marked changes. Reticular pseudodrusen formed a complex network of curvilinear lesions or interlocking ribbons, with areas between reticular pseudodrusen exhibiting no marked changes. Confluent pseudodrusen were lesions that merged or coalesced. 2 
Statistical Analysis
Associations between SNPs and baseline pseudodrusen in either eye were assessed using logistic regression models with adjustment for age, sex, and smoking status. We calculated the odds ratios and its 95% confidence intervals for genotypes and tested for linear trends in number of risk alleles. For SNPs with a significant association with presence of pseudodrusen, we performed similar analyses for each subtype of pseudodrusen. The Hochberg procedure was used to correct for the multiple comparisons from 8 SNPs. Statistical analyses were performed using SAS version 9.4 (SAS Institute). Statistical significance was set at P < .05, and all P values were 2-tailed.
Results
Among 835 patients in the genetics study, 755 (90.4%) had sufficient image quality to evaluate baseline pseudodrusen in both eyes. The mean (SD) age was 78 (7.5) years, and 471 (62.4%) were female and 73 (9.7%) were current smokers. Among these 755 participants, 213 (28.2%) had pseudodrusen in either eye and 115 (15.2%) had pseudodrusen in both eyes; 107 (14.2%) had dot pseudodrusen, 180 (23.8%) had reticular pseudodrusen, and 102 (13.5%) had confluent pseudodrusen (subtypes are not mutually exclusive).
In logistic regression models, risk of pseudodrusen increased with the number of risk alleles of ARMS2 (odds ratio, 1.93; 95% CI, 1.19-3.12) for TT vs GG and of HTRA1 (odds ratio, 2.04;95%CI,1.26-3.31)forAAvsGG.ForbothCFH Y402H and C3, risk of pseudodrusen decreased with the number of risk alleles, but the associations were not significant after correcting for multiple comparisons ( Table 1) . We did not find any significant associations with pseudodrusen for LIPC, CFB, C2, and CFH I62V. CFH Y402H, ARMS2, HTRA1, and C3 were associated with reticular pseudodrusen but were not associated with dot pseudodrusen ( Table 2) . HTRA1 was also associated with confluent pseudodrusen.
Discussion
Others have examined the association of the major AMD SNPs with pseudodrusen with conflicting results (eTable in the
Key Points
Question Are single-nucleotide polymorphisms that confer increased risk of age-related macular degeneration (AMD) associated with higher risk of pseudodrusen and subtypes of pseudodrusen?
Findings In this post hoc analysis of the Comparison of AMD Treatment Trials, among 755 patients with neovascular AMD, the AMD risk alleles of age-related maculopathy susceptibility 2 (ARMS2; rs10490924) and HtrA serine peptidase 1 (HTRA1; rs11200638) were significantly associated with an increased risk of pseudodrusen.
Meaning These findings suggest AMD single-nucleotide polymorphisms have a role in the development of pseudodrusen. Supplement), likely because of small numbers of individuals with pseudodrusen and differences in the study population. In our study of 755 CATT participants, risk alleles in ARMS2 and HTRA1 were associated with higher risk of pseudodrusen.
Most studies have shown that the risk allele T in ARMS2 is associated with higher risk of pseudodrusen [4] [5] [6] [7] [8] [9] 11 (eTable in the Supplement). Because there is high linkage disequilibrium between ARMS2 and HTRA1, HTRA1 has also been associated with pseudodrusen as well. 5, 6 While the CFH Y402H risk allele is associated with increased risk of AMD, the association of CFH Y402H with pseudodrusen has been controversial thus far. [3] [4] [5] [6] [7] [8] [9] [10] [11] Several studies of patients with AMD found no association between the CFH Y402H risk allele and pseudodrusen, 7, 8, 10 while other studies among participants with and without AMD reported an increased risk of pseudodrusen. [3] [4] [5] [6] Smith et al 11 found a decreased risk of pseudodrusen in patients with AMD, which is consistent with our finding that risk of pseudodrusen among patients with neovascular AMD decreased with the number of CFH Y402H risk alleles, although our association was not significant after correcting for multiple comparisons (eTable in the Supplement). These studies varied in their study population, with some studies evaluating the presence of SNPs in the population (with and without AMD) and other studies only evaluating those who had AMD. Population-based studies [3] [4] [5] have compared the presence of CFH Y402H in individuals with and without pseudodrusen, without consideration of AMD status. Thus, perhaps there was no true association between CFH Y402H and pseudodrusen within the AMD population or even an inverse association within patients with AMD, as we have found. Our results support the hypothesis by Smith et al 11 that CFH Y402H
confers an alternative complement response that may be protective against the development of pseudodrusen. We also evaluated the association of LIPC, CFH I62V, CFB, C2, and C3 with pseudodrusen. In contrast, Puche et al 6 showed that the risk allele of C3 was associated with higher risk of pseudodrusen when considering individuals without AMD, but there was no association among those with AMD. Pseudodrusen have different appearances in imaging and have been classified into subtypes (ie, dot, reticular, and confluent). 2 We found that dot pseudodrusen were associated with neovascular AMD, whereas confluent pseudodrusen were associated with geographic atrophy. 2 Elfandi et al 14 found no association for both ARMS2 and CFH Y402H with dot-dominant pseudodrusen vs dot-reticular pseudodrusen but found CFH I62V was more common in patients with dot-dominant pseudodrusen. Shijo et al 15 did not find any association between subtypes of pseudodrusen with CFH I62V or ARMS2. Despite the fact that our study is limited to individuals with neovascular AMD and possible misclassification of pseudodrusen, we found that the risk alleles of ARMS2 and HTRA1 were associated with higher risk of reticular pseudodrusen and confluent pseudodrusen, while the risk allele of C3 was associated with a lower risk of reticular pseudodrusen. We also found the risk allele of CFH Y402H was associated with a significantly lower risk of reticular pseudodrusen.
Conclusions
In conclusion, our results suggest that there are associations of AMD SNPs with pseudodrusen and their subtypes. Understanding the role of these AMD SNPs in the development of pseudodrusen might contribute to the understanding of the pathogenesis of pseudodrusen and ultimately to development of future therapies. 
